Filing Details

Accession Number:
0001181431-13-030396
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-23 21:00:29
Reporting Period:
2013-05-21
Filing Date:
2013-05-23
Accepted Time:
2013-05-23 21:00:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1017491 Apricus Biosciences Inc. APRI Pharmaceutical Preparations (2834) 870449967
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1283304 G Kleanthis Xanthopoulos 11975 El Camino Real, Suite 300
San Diego CA 92130
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2013-05-21 2,864 $3.36 75,783 No 4 S Indirect By Kleanthis & Gaylen Xanthopoulos TTEES, Xanthopoulos Family Trust Dtd 9/30/2011
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Kleanthis & Gaylen Xanthopoulos TTEES, Xanthopoulos Family Trust Dtd 9/30/2011
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.25 to $3.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  3. Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting Person, which are subject to certain vesting conditions.